EDGAR Filing Documents for 0001654954-18-001367

Form 8-K - Current report:

SEC Accession No. 0001654954-18-001367

Filing Date

2018-02-12

Accepted

2018-02-12 17:22:00

Documents

Period of Report

2018-02-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	mdit8k_feb62018.htm	8-K	38514
2	FORM OF SECURITIES PURCHASE AGREEMENT	ex10-1.htm	EX-10.1	211595
3	FORM OF SECURED CONVERTIBLE PROMISSORY NOTE	ex10-2.htm	EX-10.2	168408
4	FORM OF SECURITY AGREEMENT	ex10-3.htm	EX-10.3	160197
5	GUARANTY OF OBLIGATION	ex10-4.htm	EX-10.4	119887
6	SUBORDINATION AND INTERCREDITOR AGREEMENT	ex10-5.htm	EX-10.5	113500
	Complete submission text file	0001654954-18-001367.txt		813744

Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610

Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290

Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)